FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3033134243> ?p ?o ?g. }

• W3033134243 abstract "Abstract Background Cystic fibrosis is a rare recessive monogenic disease caused by loss-of-function mutations in the Cystic Fibrosis Transmembrane Conductance Regulator (CFTR) gene. Recently developed CFTR-modulators (i.e. drugs that rescue CFTR-function) have improved the prognosis of the disease, but are only available for certain, relatively common mutations. More than 2000 genetic variants in CFTR have been described, many of which are uncharacterized, while efficacy of CFTR-modulators can differ depending on genotype. Personalized models that can predict drug efficacy in patients with rare mutations could help to provide access to effective CFTR-modulator treatment. The forskolin induced swelling (FIS) assay in rectal organoids can robustly measure CFTR-function and CFTR-modulator efficacy, and pilot studies indicate that FIS accurately predicts treatment efficacy in individual patients. In the HIT-CF Organoid Study, rectal organoids from patients with rare CFTR-mutations are screened for CFTR-modulator efficacy to identify patients that could clinically benefit from these drugs. Methods In this EU-H2020 funded multi-centre study, rectal biopsies are obtained from approximately 500 subjects with rare CFTR-mutations from 17 different EU countries and sent to central laboratories. Organoids are generated, on which several novel CFTR-modulating drugs are screened for efficacy. In the process, a biobank is generated which could be used for future research. Subjects whose organoids show a response to treatment will be asked to participate in subsequent clinical trials evaluating the clinical efficacy of tested drugs. Discussion The HIT-CF Organoid Study applies the intestinal organoid model for personalized medicine in patients with rare variant cystic fibrosis, who are currently excluded from classical CFTR-modulator trials. Together with the subsequent clinical trials in high responders, this study aims to create a new pathway for access to CFTR-modulating drugs for patients with ultra-rare CFTR variants. Trial registration This trial has been registered in the Netherlands Trial Registry (NTR7520, https://www.trialregister.nl/trial/7304 ), a primary registry approved and recognized by WMO and ICMJE, on 2018-10-02." @default.
• W3033134243 created "2020-06-12" @default.
• W3033134243 creator A5014845511 @default.
• W3033134243 creator A5015719837 @default.
• W3033134243 creator A5027077813 @default.
• W3033134243 creator A5027795483 @default.
• W3033134243 creator A5088428340 @default.
• W3033134243 date "2020-06-03" @default.
• W3033134243 modified "2023-10-16" @default.
• W3033134243 title "Rationale and design of the HIT-CF organoid study: stratifying cystic fibrosis patients based on intestinal organoid response to different CFTR-modulators" @default.
• W3033134243 cites W1117291148 @default.
• W3033134243 cites W1589654967 @default.
• W3033134243 cites W1991672758 @default.
• W3033134243 cites W1997114875 @default.
• W3033134243 cites W2031633609 @default.
• W3033134243 cites W2035131077 @default.
• W3033134243 cites W2071407356 @default.
• W3033134243 cites W2085811948 @default.
• W3033134243 cites W2094403854 @default.
• W3033134243 cites W2115046089 @default.
• W3033134243 cites W2125391335 @default.
• W3033134243 cites W2151829259 @default.
• W3033134243 cites W2316431812 @default.
• W3033134243 cites W2337925307 @default.
• W3033134243 cites W2441337908 @default.
• W3033134243 cites W2465114161 @default.
• W3033134243 cites W2587150600 @default.
• W3033134243 cites W2794029576 @default.
• W3033134243 cites W2888781195 @default.
• W3033134243 cites W2893878927 @default.
• W3033134243 cites W2911418673 @default.
• W3033134243 cites W2982517646 @default.
• W3033134243 cites W2982641061 @default.
• W3033134243 cites W2985142745 @default.
• W3033134243 cites W2985405196 @default.
• W3033134243 cites W3006654506 @default.
• W3033134243 cites W3032959380 @default.
• W3033134243 cites W4241473661 @default.
• W3033134243 cites W844779258 @default.
• W3033134243 doi "https://doi.org/10.1186/s41231-020-00060-3" @default.
• W3033134243 hasPublicationYear "2020" @default.
• W3033134243 type Work @default.
• W3033134243 sameAs 3033134243 @default.
• W3033134243 citedByCount "10" @default.
• W3033134243 countsByYear W30331342432020 @default.
• W3033134243 countsByYear W30331342432021 @default.
• W3033134243 countsByYear W30331342432022 @default.
• W3033134243 countsByYear W30331342432023 @default.
• W3033134243 crossrefType "journal-article" @default.
• W3033134243 hasAuthorship W3033134243A5014845511 @default.
• W3033134243 hasAuthorship W3033134243A5015719837 @default.
• W3033134243 hasAuthorship W3033134243A5027077813 @default.
• W3033134243 hasAuthorship W3033134243A5027795483 @default.
• W3033134243 hasAuthorship W3033134243A5088428340 @default.
• W3033134243 hasBestOaLocation W30331342431 @default.
• W3033134243 hasConcept C126322002 @default.
• W3033134243 hasConcept C2776502428 @default.
• W3033134243 hasConcept C2776938444 @default.
• W3033134243 hasConcept C2778428886 @default.
• W3033134243 hasConcept C31695470 @default.
• W3033134243 hasConcept C502942594 @default.
• W3033134243 hasConcept C54355233 @default.
• W3033134243 hasConcept C60644358 @default.
• W3033134243 hasConcept C71924100 @default.
• W3033134243 hasConcept C86803240 @default.
• W3033134243 hasConcept C98274493 @default.
• W3033134243 hasConceptScore W3033134243C126322002 @default.
• W3033134243 hasConceptScore W3033134243C2776502428 @default.
• W3033134243 hasConceptScore W3033134243C2776938444 @default.
• W3033134243 hasConceptScore W3033134243C2778428886 @default.
• W3033134243 hasConceptScore W3033134243C31695470 @default.
• W3033134243 hasConceptScore W3033134243C502942594 @default.
• W3033134243 hasConceptScore W3033134243C54355233 @default.
• W3033134243 hasConceptScore W3033134243C60644358 @default.
• W3033134243 hasConceptScore W3033134243C71924100 @default.
• W3033134243 hasConceptScore W3033134243C86803240 @default.
• W3033134243 hasConceptScore W3033134243C98274493 @default.
• W3033134243 hasFunder F4320332999 @default.
• W3033134243 hasIssue "1" @default.
• W3033134243 hasLocation W30331342431 @default.
• W3033134243 hasLocation W30331342432 @default.
• W3033134243 hasOpenAccess W3033134243 @default.
• W3033134243 hasPrimaryLocation W30331342431 @default.
• W3033134243 hasRelatedWork W2036338268 @default.
• W3033134243 hasRelatedWork W2128475838 @default.
• W3033134243 hasRelatedWork W2409415991 @default.
• W3033134243 hasRelatedWork W2415708160 @default.
• W3033134243 hasRelatedWork W3168010511 @default.
• W3033134243 hasRelatedWork W3207946969 @default.
• W3033134243 hasRelatedWork W4281738576 @default.
• W3033134243 hasRelatedWork W4281771725 @default.
• W3033134243 hasRelatedWork W4281795637 @default.
• W3033134243 hasRelatedWork W4379979931 @default.
• W3033134243 hasVolume "5" @default.
• W3033134243 isParatext "false" @default.
• W3033134243 isRetracted "false" @default.
• W3033134243 magId "3033134243" @default.
• W3033134243 workType "article" @default.